Researchers identify several new genetic risk factors for Alzheimer's disease unique to Ashkenazi Jews

United Kingdom News News

Researchers identify several new genetic risk factors for Alzheimer's disease unique to Ashkenazi Jews
United Kingdom Latest News,United Kingdom Headlines
  • 📰 medical_xpress
  • ⏱ Reading Time:
  • 69 sec. here
  • 3 min. at publisher
  • 📊 Quality Score:
  • News: 31%
  • Publisher: 51%

Researchers identify several new geneticriskfactors for Alzheimer'sdisease unique to Ashkenazi Jews BUMedicine

For many centuries, Ashkenazi Jews lived in communities in Eastern Europe and were genetically isolated from their non-Jewish neighbors. As a result, researchers from Boston University Chobanian & Avedisian School of Medicine have hypothesized that some AD susceptibility variants are more frequent, and thus more likely to show statistically significant associations in this group compared to much larger and more genetically heterogeneous EA cohorts.

Farrer and his colleagues conducted a genome-wide association study for AD in a sample of approximately 3,500 individuals whose ancestry was almost exclusively Ashkenazi Jewish, including roughly equal numbers of persons with AD and cognitively normal individuals who were identified in a much larger group of EA participants in large national AD genetics studies using an approach that compared genetic signatures with members of an Ashkenazi Jewish reference sample.

According to the researchers, this study illustrates the greatly increased power for detection of genetic associations in communities like Ashkenazi Jews who trace their lineage to a relatively small group of ancestors."Some genetic association signals for complex diseases like AD are likely to be stronger in founder populations that are relatively genetically homogeneous," said Farrer.

Although some of the findings in Ashkenazi Jews were not observed in other populations because of the rarity or absence of these genetic variants in those groups, Farrer believes the contribution of the genes harboring these variants to AD biology is likely relevant to other major populations in the world."Future studies focused on the AD-associated genes identified in this study may lead to the development of novel AD biomarkers and therapeutic targets," he said.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

medical_xpress /  🏆 101. in UK

United Kingdom Latest News, United Kingdom Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Researchers find oldest evidence of the plague in BritainResearchers find oldest evidence of the plague in BritainScientists discover 4,000 year-old plague DNA - the oldest evidence of the disease in Britain.
Read more »

Biomarker study reveals the effects of astrocyte reactivity in preclinical Alzheimer's diseaseBiomarker study reveals the effects of astrocyte reactivity in preclinical Alzheimer's diseaseBiomarker study reveals the effects of astrocyte reactivity in preclinical Alzheimer's disease NatureMedicine PittTweet biomarker alzheimers alzheimersdisease AD astrocyte preclinical
Read more »

Q&A: Researchers discover new, more effective candidates for treatment of syphilisQ&A: Researchers discover new, more effective candidates for treatment of syphilisSince 2000, sexually transmitted infection rates have been on the rise. Syphilis, a disease that was nearly eradicated in the United States at that time, now affects more than 18 million people worldwide each year with few options for effective treatment.
Read more »

Mpox incidence across rural and urban areas in the USMpox incidence across rural and urban areas in the USMpox incidence across rural and urban areas in the US CDCMMWR CDCgov mpox incidence publichealth health cdc CDC rates rural urban
Read more »

NmCV-5 vaccine safety and immunogenicity against bacterial meningitis in Mali and GambiaNmCV-5 vaccine safety and immunogenicity against bacterial meningitis in Mali and GambiaNmCV-5 vaccine safety and immunogenicity against bacterial meningitis in Mali and Gambia NEJM vaccine immunogenicity meningitis africa maliandgambia vaccinesafety publichealth
Read more »

Interim results of the effectiveness of 2022-2023 influenza vaccine from six studies conducted in EuropeInterim results of the effectiveness of 2022-2023 influenza vaccine from six studies conducted in EuropeInterim results of the effectiveness of 2022-2023 influenza vaccine from six studies conducted in Europe Eurosurveillanc vaccine influenza europe studies efficacy effectiveness
Read more »



Render Time: 2025-02-16 10:15:56